Rituximab vs Tinzaparin Sodium

## Rituximab vs Tinzaparin Sodium: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Tinzaparin Sodium**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Tinzaparin Sodium — N/A.

## Chemical Properties

**Type**: Rituximab — Antibody; Tinzaparin Sodium — Oligosaccharide.